Sienna Biopharmaceutica Pink Sheet Forecast - Naive Prediction

SNNAQ Stock  USD 0.0001  0.00  0.00%   
The Naive Prediction forecasted value of Sienna Biopharmaceuticals on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Sienna Pink Sheet Forecast is based on your current time horizon.
As of today the relative strength index (rsi) of Sienna Biopharmaceutica's share price is below 20 . This usually implies that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Sienna Biopharmaceutica's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Sienna Biopharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Using Sienna Biopharmaceutica hype-based prediction, you can estimate the value of Sienna Biopharmaceuticals from the perspective of Sienna Biopharmaceutica response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Sienna Biopharmaceuticals on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0 and the sum of the absolute errors of 0.

Sienna Biopharmaceutica after-hype prediction price

    
  USD 1.0E-4  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Historical Fundamental Analysis of Sienna Biopharmaceutica to cross-verify your projections.

Sienna Biopharmaceutica Additional Predictive Modules

Most predictive techniques to examine Sienna price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sienna using various technical indicators. When you analyze Sienna charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A naive forecasting model for Sienna Biopharmaceutica is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Sienna Biopharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Sienna Biopharmaceutica Naive Prediction Price Forecast For the 24th of January

Given 90 days horizon, the Naive Prediction forecasted value of Sienna Biopharmaceuticals on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.
Please note that although there have been many attempts to predict Sienna Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sienna Biopharmaceutica's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Sienna Biopharmaceutica Pink Sheet Forecast Pattern

Backtest Sienna BiopharmaceuticaSienna Biopharmaceutica Price PredictionBuy or Sell Advice 

Sienna Biopharmaceutica Forecasted Value

In the context of forecasting Sienna Biopharmaceutica's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Sienna Biopharmaceutica's downside and upside margins for the forecasting period are 0.0001 and 0.0001, respectively. We have considered Sienna Biopharmaceutica's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.0001
0.0001
Downside
0.0001
Expected Value
0.0001
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Sienna Biopharmaceutica pink sheet data series using in forecasting. Note that when a statistical model is used to represent Sienna Biopharmaceutica pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria30.385
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0
MAPEMean absolute percentage error0.0
SAESum of the absolute errors0.0
This model is not at all useful as a medium-long range forecasting tool of Sienna Biopharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Sienna Biopharmaceutica. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Sienna Biopharmaceutica

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sienna Biopharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Bollinger
Band Projection (param)
LowMiddleHigh
0.00010.00010.0001
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Sienna Biopharmaceutica. Your research has to be compared to or analyzed against Sienna Biopharmaceutica's peers to derive any actionable benefits. When done correctly, Sienna Biopharmaceutica's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Sienna Biopharmaceuticals.

Sienna Biopharmaceutica After-Hype Price Prediction Density Analysis

As far as predicting the price of Sienna Biopharmaceutica at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sienna Biopharmaceutica or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Sienna Biopharmaceutica, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Sienna Biopharmaceutica Estimiated After-Hype Price Volatility

In the context of predicting Sienna Biopharmaceutica's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sienna Biopharmaceutica's historical news coverage. Sienna Biopharmaceutica's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Sienna Biopharmaceutica's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.0001
0.0001
After-hype Price
0.00
Upside
Sienna Biopharmaceutica is very steady at this time. Analysis and calculation of next after-hype price of Sienna Biopharmaceuticals is based on 3 months time horizon.

Sienna Biopharmaceutica Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Sienna Biopharmaceutica is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sienna Biopharmaceutica backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sienna Biopharmaceutica, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
6 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.0001
0.0001
0.00 
0.00  
Notes

Sienna Biopharmaceutica Hype Timeline

Sienna Biopharmaceuticals is at this time traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Sienna is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Sienna Biopharmaceutica is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has price-to-book ratio of 0.0. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sienna Biopharmaceuticals recorded a loss per share of 1.8. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be within a week.
Check out Historical Fundamental Analysis of Sienna Biopharmaceutica to cross-verify your projections.

Sienna Biopharmaceutica Related Hype Analysis

Having access to credible news sources related to Sienna Biopharmaceutica's direct competition is more important than ever and may enhance your ability to predict Sienna Biopharmaceutica's future price movements. Getting to know how Sienna Biopharmaceutica's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sienna Biopharmaceutica may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
RCKTRocket Pharmaceuticals 0.10 10 per month 3.34  0.0001  8.04 (5.57) 16.20 
AURAAura Biosciences(0.33)8 per month 2.82 (0.01) 5.23 (5.88) 18.08 
ANNXAnnexon 0.31 12 per month 3.30  0.22  11.30 (7.54) 35.10 
SLDBSolid Biosciences LLC(0.27)10 per month 4.46  0.05  11.36 (7.56) 21.63 
ALTAltimmune(0.10)7 per month 4.47  0.06  7.61 (4.73) 33.75 
AUTLAutolus Therapeutics 0.03 10 per month 5.23 (0.01) 10.45 (8.67) 30.76 
DBVTDBV Technologies 0.31 10 per month 3.85  0.09  10.53 (6.66) 36.36 
DSGNDesign Therapeutics(0.79)6 per month 3.63  0.13  9.28 (6.97) 29.54 
KRROFrequency Therapeutics 0.30 6 per month 0.00 (0.08) 10.98 (8.07) 91.55 

Other Forecasting Options for Sienna Biopharmaceutica

For every potential investor in Sienna, whether a beginner or expert, Sienna Biopharmaceutica's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sienna Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sienna. Basic forecasting techniques help filter out the noise by identifying Sienna Biopharmaceutica's price trends.

Sienna Biopharmaceutica Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sienna Biopharmaceutica pink sheet to make a market-neutral strategy. Peer analysis of Sienna Biopharmaceutica could also be used in its relative valuation, which is a method of valuing Sienna Biopharmaceutica by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Sienna Biopharmaceutica Market Strength Events

Market strength indicators help investors to evaluate how Sienna Biopharmaceutica pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sienna Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying Sienna Biopharmaceutica pink sheet market strength indicators, traders can identify Sienna Biopharmaceuticals entry and exit signals to maximize returns.

Story Coverage note for Sienna Biopharmaceutica

The number of cover stories for Sienna Biopharmaceutica depends on current market conditions and Sienna Biopharmaceutica's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sienna Biopharmaceutica is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sienna Biopharmaceutica's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Sienna Biopharmaceutica Short Properties

Sienna Biopharmaceutica's future price predictability will typically decrease when Sienna Biopharmaceutica's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sienna Biopharmaceuticals often depends not only on the future outlook of the potential Sienna Biopharmaceutica's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sienna Biopharmaceutica's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding20.4 M
Cash And Short Term Investments48.5 M

Additional Tools for Sienna Pink Sheet Analysis

When running Sienna Biopharmaceutica's price analysis, check to measure Sienna Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sienna Biopharmaceutica is operating at the current time. Most of Sienna Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sienna Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sienna Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sienna Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.